These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7638963)

  • 1. [Contemporary strategies and methods of modeling antiparasitic drugs].
    Boczoń K
    Wiad Parazytol; 1995; 41(1):43-52. PubMed ID: 7638963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
    Seebach D; Beck AK; Bierbaum DJ
    Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods of computer-assisted molecular modeling].
    Náray-Szabó G
    Acta Pharm Hung; 1998 Jan; 68(1):7-13. PubMed ID: 9528144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An introduction to the computer-aided structure-based drug design--applications of bioinformatics to drug discovery].
    Hirono S
    Rinsho Byori; 2002 Jan; 50(1):45-51. PubMed ID: 11871136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of pharmacodynamics and their applications in veterinary pharmacology.
    Lees P; Cunningham FM; Elliott J
    J Vet Pharmacol Ther; 2004 Dec; 27(6):397-414. PubMed ID: 15601436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entamoeba histolytica: computer-assisted modeling of phosphofructokinase for the prediction of broad-spectrum antiparasitic agents.
    Byington CL; Dunbrack RL; Whitby FG; Cohen FE; Agabian N
    Exp Parasitol; 1997 Nov; 87(3):194-202. PubMed ID: 9371084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New antifungal and antiparasitic molecules].
    Esterre P; Jamet P
    Med Trop (Mars); 1987; 47(1):47-52. PubMed ID: 3586972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-aided drug design: crystallography and computational approaches.
    Ringe D
    J Nucl Med; 1995 Jun; 36(6 Suppl):28S-30S. PubMed ID: 7769464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-hairpin peptidomimetics: design, structures and biological activities.
    Robinson JA
    Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large-scale computational approach to drug repositioning.
    Li YY; An J; Jones SJ
    Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modelling of drug targets: the past, the present and the future.
    Dahl SG; Sylte I
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):151-5. PubMed ID: 15733208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
    Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A "FRankenstein's monster" approach to comparative modeling: merging the finest fragments of Fold-Recognition models and iterative model refinement aided by 3D structure evaluation.
    Kosinski J; Cymerman IA; Feder M; Kurowski MA; Sasin JM; Bujnicki JM
    Proteins; 2003; 53 Suppl 6():369-79. PubMed ID: 14579325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling and docking analysis of Entamoeba histolytica glyceraldehyde-3 phosphate dehydrogenase, a potential target enzyme for anti-protozoal drug development.
    Singh S; Malik BK; Sharma DK
    Chem Biol Drug Des; 2008 Jun; 71(6):554-62. PubMed ID: 18489439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.